Profil
Jennifer Hansson is the founder and current Chief Executive Officer of Akuru Pharma AB, which is founded in 2016.
Postes actifs de Jennifer Hansson
| Sociétés | Poste | Début |
|---|---|---|
Akuru Pharma AB
 Akuru Pharma AB BiotechnologyHealth Technology Akuru Pharma AB engages in the development of research and technology. It focuses on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities. The company was founded by Jennifer Hansson, Hakan Axelson, and Johanna Asklin on April 14, 2016 and is headquareterd in Lund, Sweden. | Directeur Général | 14/04/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Akuru Pharma AB
Akuru Pharma AB BiotechnologyHealth Technology Akuru Pharma AB engages in the development of research and technology. It focuses on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities. The company was founded by Jennifer Hansson, Hakan Axelson, and Johanna Asklin on April 14, 2016 and is headquareterd in Lund, Sweden. | Health Technology |
